Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)
Year: 2019
Type: review
Authors: Concepción Sánchez-Martínez, María José Lallena, Sonia Gutiérrez Sanfeliciano, Alfonso de Dios
Institutions: Eli Lilly (Spain), Eli Lilly (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2970349558
